Also trades as: INCR (NASDAQ) · $vol 0M
INCR.TA TLV
InterCure Ltd.
1W: +0.5%
1M: -1.3%
3M: +434.3%
YTD: +480.8%
1Y: +202.9%
3Y: +134.0%
5Y: +12.9%
₪1,689.00 ($5.55)
+12.00 (+0.72%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$239M
-32.8% ▼
5Y CAGR: +93.0%
Gross Profit
$30M
-71.2% ▼
5Y CAGR: +82.9%
Operating Income
-$67M
-61.7% ▼
Net Income
-$68M
-9.4% ▼
EPS (Diluted)
$-1.48
-8.8% ▼
EBITDA
-$51M
-114.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $65M | $220M | $389M | $356M | $239M |
| YoY Growth | +628.6% | +237.8% | +76.9% | -8.5% | -32.8% |
| Cost of Revenue | $33M | $129M | $234M | $250M | $209M |
| Gross Profit | $32M | $91M | $155M | $105M | $30M |
| Gross Margin | 49.2% | 41.5% | 39.9% | 29.6% | 12.7% |
| R&D Expenses | $2M | $1M | $632K | $388K | $414K |
| SG&A Expenses | $26M | $53M | $97M | $86M | $85M |
| Operating Expenses | $70M | $63M | $95M | $147M | $97M |
| Operating Income | -$38M | $28M | $51M | -$42M | -$67M |
| Operating Margin | -59.0% | 12.8% | 13.0% | -11.7% | -28.1% |
| Interest Expense | $528K | $5M | $15M | $24M | $23M |
| Income Before Tax | -$38M | $19M | $44M | -$61M | -$87M |
| Tax Expense | -$2M | $11M | $93K | $2M | -$15M |
| Net Income | -$37M | $5M | $45M | -$62M | -$68M |
| Net Margin | -57.2% | 2.1% | 11.5% | -17.4% | -28.4% |
| EPS (Diluted) | $-1.47 | $0.11 | $0.99 | $-1.36 | $-1.48 |
| EBITDA | -$35M | $31M | $70M | -$24M | -$51M |
| Shares Outstanding | 25M | 41M | 45M | 46M | 46M |